Tag: physical sciences
-
Neuro Disease Start-Up Raises $73M in Early Funds
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round.
-
Trial Testing Lymphoma Drug to Treat Covid-19
A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections.
-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.
-
Tough Surgical Adhesive Commercially Licensed
A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab.
-
Cancer Protein Therapy Biotech Raises $400M in IPO
A three year-old company developing protein-targeted cancer therapies with computational techniques is raising $400 million in its initial public offering of common stock.
-
Coating Deactivates Covid-19 Viruses on Surfaces
A chemical engineering lab developed a coating that when applied to surfaces quickly inactivates viruses responsible for Covid-19 infections.
-
New Company Offers A.I. Aging Biomarker Analysis
A new enterprise is underway using artificial intelligence to analyze a person’s body chemistry and calculate the likelihood of age-related diseases.
-
Challenge Seeks Next-Generation Face Mask
A challenge competition with a total purse of $1 million seeks a new type of face mask that people will be eager to wear to protect against infectious diseases.
-
Infographic – Apple Leads in A.I. Acquistions
Among the tech giants, Apple is the most aggressive in acquiring start-ups developing A.I. applications over the past 10 years.